Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data — Stella

Home/Hepatitis C Virus (HCV)/Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data

View on ClinicalTrials.gov

Recruiting

Back to Hepatitis C Virus (HCV) trials

Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data

Trial locations(2 sites)

Canada

Vancouver Infectious Diseases Centre /ID# 275313, Vancouver, British Columbia

St. Clair Medical Clinic /ID# 275334, Toronto, Ontario

Key details

Sponsor

AbbVie

Enrollment target

~2,000 participants

Started

February 2026

Primary completion

June 2026

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.